Severe acute respiratory syndrome: identification of the etiological agent
- PMID: 12928032
- PMCID: PMC7128529
- DOI: 10.1016/s1471-4914(03)00133-3
Severe acute respiratory syndrome: identification of the etiological agent
Abstract
The severe acute respiratory syndrome (SARS) emerged in late 2002 in southern China and rapidly spread to countries around the globe. Three research groups within a World Health Organization (WHO)-coordinated network have independently and simultaneously shown that a novel coronavirus is linked to SARS. A fourth group has completed the Koch's postulates by infecting monkeys with the agent. Sequencing of the complete genome was achieved only weeks after the first isolate of the virus became available.
Figures
Similar articles
-
[Progresses in studies on SARS-associated coronavirus].Zhonghua Er Ke Za Zhi. 2003 Aug;41(8):635-9. Zhonghua Er Ke Za Zhi. 2003. PMID: 14744401 Review. Chinese. No abstract available.
-
[SARS-CoV: 1. The virus].Med Sci (Paris). 2003 Aug-Sep;19(8-9):885-91. doi: 10.1051/medsci/20031989885. Med Sci (Paris). 2003. PMID: 14593622 Review. French. No abstract available.
-
[Isolation and identification of the infective agent of severe acute respiratory syndrome (SARS) from a patient with atypical pneumonia].Zh Mikrobiol Epidemiol Immunobiol. 2003 Sep-Oct;(5):109-12. Zh Mikrobiol Epidemiol Immunobiol. 2003. PMID: 14565137 Russian.
-
A novel coronavirus associated with severe acute respiratory syndrome.N Engl J Med. 2003 May 15;348(20):1953-66. doi: 10.1056/NEJMoa030781. Epub 2003 Apr 10. N Engl J Med. 2003. PMID: 12690092
-
Analysis of severe acute respiratory syndrome coronavirus structural proteins in virus-like particle assembly.Microbiol Immunol. 2008 Dec;52(12):625-30. doi: 10.1111/j.1348-0421.2008.00079.x. Microbiol Immunol. 2008. PMID: 19120977 Free PMC article.
Cited by
-
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.J Virol. 2024 May 14;98(5):e0169323. doi: 10.1128/jvi.01693-23. Epub 2024 Apr 2. J Virol. 2024. PMID: 38563763 Free PMC article.
-
Recovery from Resistance Exercise in Older Adults: A Systematic Scoping Review.Sports Med Open. 2023 Jul 3;9(1):51. doi: 10.1186/s40798-023-00597-1. Sports Med Open. 2023. PMID: 37395837 Free PMC article.
-
Emerging Multiplex Nucleic Acid Diagnostic Tests for Combating COVID-19.Biosensors (Basel). 2022 Nov 7;12(11):978. doi: 10.3390/bios12110978. Biosensors (Basel). 2022. PMID: 36354487 Free PMC article. Review.
-
Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis.PLoS One. 2022 May 31;17(5):e0268909. doi: 10.1371/journal.pone.0268909. eCollection 2022. PLoS One. 2022. PMID: 35639751 Free PMC article.
-
A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest.Viruses. 2021 Nov 29;13(12):2386. doi: 10.3390/v13122386. Viruses. 2021. PMID: 34960655 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous